Chargement de la fiche…
Chargement de la fiche…
rhumatologie
Hospitalier
Caen (14076)
Multiple Myeloma Research and Treatments · Cancer Treatment and Pharmacology · Hematopoietic Stem Cell Transplantation
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
2021–2024
Université de Caen Normandie
2021–2022
Centre Hospitalier Universitaire de Caen Normandie
2018–2020
Inserm
2018–2020
Sorbonne Université
2018–2020
Centre de Recherche Saint-Antoine
2019
Vaincre la Mucoviscidose
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 3 articles cités au moins 3fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Côté patient
Comprendre votre pathologie, exercices à domicile, applications validées, paramédicaux à proximité — gratuit, sans inscription.
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
0
travaux
0
h-index
0
i10-index
0
citations
2024Annals of hematology
PubMed ↗Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B‑cell lymphoma: results of a multicentric prospective cohort study
2023Annals of hematology
PubMed ↗Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study
2024Annals of hematology
PubMed ↗Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B‑cell lymphoma: results of a multicentric prospective cohort study
2023Annals of hematology
PubMed ↗Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study
2018Joint bone spine
PubMed ↗Bone sarcoidosis
2024Article
Impact of second autologous stem‐cell transplantation at relapsed multiple myeloma: A French multicentric real‐life study
HemaSphere
2022Congrès
What Is the Benefit of Autologous Stem Cell Transplantation in Multiple Myeloma Beyond the Age of 65? Inputs from Real-World Data in the Emmy Cohort
64th ASH Annual Meeting and Exposition
2020Article
High‐dose post‐transplant cyclophosphamide impairs γδ T‐cell reconstitution after haploidentical haematopoietic stem cell transplantation using low‐dose antithymocyte globulin and peripheral blood stem cell graft
Clinical and Translational Immunology
2018Article
Bone sarcoidosis
Joint Bone Spine
Rhumatologues à proximité